Cargando…
Cell Fate Decisions During Breast Cancer Development
During the formation of breast cancer, many genes become altered as cells evolve progressively from normal to a pre-malignant to a malignant state of growth. How mutations in genes lead to specific subtypes of human breast cancer is only partially understood. Here we review how initial genetic or ep...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840277/ https://www.ncbi.nlm.nih.gov/pubmed/27110512 http://dx.doi.org/10.3390/jdb4010004 |
_version_ | 1782428253209755648 |
---|---|
author | Gross, Kayla Wronski, Ania Skibinski, Adam Phillips, Sarah Kuperwasser, Charlotte |
author_facet | Gross, Kayla Wronski, Ania Skibinski, Adam Phillips, Sarah Kuperwasser, Charlotte |
author_sort | Gross, Kayla |
collection | PubMed |
description | During the formation of breast cancer, many genes become altered as cells evolve progressively from normal to a pre-malignant to a malignant state of growth. How mutations in genes lead to specific subtypes of human breast cancer is only partially understood. Here we review how initial genetic or epigenetic alterations within mammary epithelial cells (MECs) can alter cell fate decisions and put pre-malignant cells on a path towards cancer development with specific phenotypes. Understanding the early stages of breast cancer initiation and progression and how normal developmental processes are hijacked during transformation has significant implications for improving early detection and prevention of breast cancer. In addition, insights gleaned from this understanding may also be important for developing subtype-specific treatment options. |
format | Online Article Text |
id | pubmed-4840277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-48402772016-04-22 Cell Fate Decisions During Breast Cancer Development Gross, Kayla Wronski, Ania Skibinski, Adam Phillips, Sarah Kuperwasser, Charlotte J Dev Biol Review During the formation of breast cancer, many genes become altered as cells evolve progressively from normal to a pre-malignant to a malignant state of growth. How mutations in genes lead to specific subtypes of human breast cancer is only partially understood. Here we review how initial genetic or epigenetic alterations within mammary epithelial cells (MECs) can alter cell fate decisions and put pre-malignant cells on a path towards cancer development with specific phenotypes. Understanding the early stages of breast cancer initiation and progression and how normal developmental processes are hijacked during transformation has significant implications for improving early detection and prevention of breast cancer. In addition, insights gleaned from this understanding may also be important for developing subtype-specific treatment options. MDPI 2016-01-22 /pmc/articles/PMC4840277/ /pubmed/27110512 http://dx.doi.org/10.3390/jdb4010004 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gross, Kayla Wronski, Ania Skibinski, Adam Phillips, Sarah Kuperwasser, Charlotte Cell Fate Decisions During Breast Cancer Development |
title | Cell Fate Decisions During Breast Cancer Development |
title_full | Cell Fate Decisions During Breast Cancer Development |
title_fullStr | Cell Fate Decisions During Breast Cancer Development |
title_full_unstemmed | Cell Fate Decisions During Breast Cancer Development |
title_short | Cell Fate Decisions During Breast Cancer Development |
title_sort | cell fate decisions during breast cancer development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840277/ https://www.ncbi.nlm.nih.gov/pubmed/27110512 http://dx.doi.org/10.3390/jdb4010004 |
work_keys_str_mv | AT grosskayla cellfatedecisionsduringbreastcancerdevelopment AT wronskiania cellfatedecisionsduringbreastcancerdevelopment AT skibinskiadam cellfatedecisionsduringbreastcancerdevelopment AT phillipssarah cellfatedecisionsduringbreastcancerdevelopment AT kuperwassercharlotte cellfatedecisionsduringbreastcancerdevelopment |